ELEVANCE HEALTH INC (ELV) Stock Earnings & Estimates
NYSE:ELV - US0367521038 - Common Stock
308.05 USD
-13.54 (-4.21%)
308.05 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 156.595B 12.95% | 171.34B 9.42% | 176.81B 3.19% | 198.779B 12.43% | 209.816B 5.55% | 222.355B 5.98% | 238.986B 7.48% | 271.901B 13.77% | N/A | N/A | N/A | |
| EBITDA YoY % growth | 10.165B -2.79% | 11.242B 10.60% | 10.549B -6.16% | 10.559B 0.09% | 10.792B 2.21% | 11.853B 9.83% | 14.284B 20.51% | 16.243B 13.71% | 17.858B 9.94% | 19.347B 8.34% | 20.502B 5.97% | |
| EBIT YoY % growth | 8.49B -7.26% | 9.497B 11.86% | 9.156B -3.59% | 9.715B 6.11% | 10.249B 5.50% | 10.842B 5.79% | 14.72B 35.77% | N/A | N/A | N/A | N/A | |
| Operating Margin | 5.42% | 5.54% | 5.18% | 4.89% | 4.88% | 4.88% | 6.16% | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | 29.05 11.86% | 33.11 13.98% | 32.97 -0.42% | 30.19 -8.42% | 31.86 5.50% | 36.69 15.18% | 45.52 24.05% | 50.25 10.40% | 62.60 24.58% | 67.92 8.50% | 73.68 8.48% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 4.98 -40.55% | 4.18 8.75% | 12.48 4.27% | 9.17 3.76% | 6.31 26.90% | 3.96 -5.14% | 13.90 11.39% | 10.81 17.88% | 7.34 16.21% | 4.84 22.05% |
| Revenue Q2Q % growth | 49.753B 11.26% | 50.071B 11.30% | 51.979B 6.59% | 53.28B 7.81% | 52.539B 5.60% | 52.879B 5.61% | 54.8B 5.43% | 56.502B 6.05% | 55.287B 5.23% | 55.499B 4.95% |
| EBITDA Q2Q % growth | 1.955B -34.29% | 1.505B -35.66% | 4.089B 16.36% | 3.194B -5.67% | 2.148B 9.87% | 1.596B 6.05% | 4.328B 5.84% | 3.548B 11.08% | 2.359B 9.82% | 1.776B 11.28% |
| EBIT Q2Q % growth | 1.934B -2.32% | 1.383B 46.19% | 3.629B 15.54% | 2.783B 5.70% | 1.976B 2.17% | 1.239B -10.41% | 3.932B 8.35% | 3.095B 11.21% | 2.174B 10.02% | 1.385B 11.78% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 8.84 -12.65% | 9.04 | -0.20 | -2.26% |
| Q1 2025 Q2Q % growth | 11.97 12.50% | 11.50 | 0.47 | 4.12% |
| Q4 2024 Q2Q % growth | 3.84 -31.67% | 3.83 | 0.01 | 0.17% |
| Q3 2024 Q2Q % growth | 8.37 -6.90% | 9.76 | -1.39 | -14.20% |
| Q2 2024 Q2Q % growth | 10.12 11.95% | 10.11 | 0.01 | 0.10% |
| Q1 2024 Q2Q % growth | 10.64 12.47% | 10.64 | 0.00 | 0.03% |
| Q4 2023 Q2Q % growth | 5.62 7.46% | 5.70 | -0.08 | -1.40% |
| Q3 2023 Q2Q % growth | 8.99 19.39% | 8.52 | 0.47 | 5.47% |
| Q2 2023 Q2Q % growth | 9.04 12.44% | 8.88 | 0.16 | 1.75% |
| Q1 2023 Q2Q % growth | 9.46 14.67% | 9.35 | 0.11 | 1.13% |
| Q4 2022 Q2Q % growth | 5.23 1.75% | 5.24 | -0.01 | -0.20% |
| Q3 2022 Q2Q % growth | 7.53 10.90% | 7.22 | 0.31 | 4.30% |
| Q2 2022 Q2Q % growth | 8.04 14.37% | 7.82 | 0.22 | 2.84% |
| Q1 2022 Q2Q % growth | 8.25 17.69% | 7.89 | 0.36 | 4.54% |
| Q4 2021 Q2Q % growth | 5.14 102.36% | 5.16 | -0.02 | -0.46% |
| Q3 2021 Q2Q % growth | 6.79 61.67% | 6.43 | 0.36 | 5.53% |
| Q2 2021 Q2Q % growth | 7.03 -23.59% | 6.40 | 0.63 | 9.93% |
| Q1 2021 Q2Q % growth | 7.01 8.18% | 6.58 | 0.43 | 6.57% |
| Q4 2020 Q2Q % growth | 2.54 -34.54% | 2.55 | -0.01 | -0.21% |
| Q3 2020 Q2Q % growth | 4.20 -13.76% | 4.19 | 0.01 | 0.15% |
| Q2 2020 Q2Q % growth | 9.20 98.28% | 8.96 | 0.24 | 2.64% |
| Q1 2020 Q2Q % growth | 6.48 7.46% | 6.54 | -0.06 | -0.94% |
| Q4 2019 Q2Q % growth | 3.88 | 3.92 | -0.04 | -1.06% |
| Q3 2019 Q2Q % growth | 4.87 | 4.87 | 0.00 | 0.03% |
| Q2 2019 Q2Q % growth | 4.64 | 4.66 | -0.02 | -0.43% |
| Q1 2019 Q2Q % growth | 6.03 | 5.87 | 0.16 | 2.68% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 49.421B 14.34% | 48.717B | 704M | 1.45% |
| Q1 2025 Q2Q % growth | 48.765B 15.36% | 46.753B | 2.012B | 4.30% |
| Q4 2024 Q2Q % growth | 44.989B 5.97% | 45.311B | -322M | -0.71% |
| Q3 2024 Q2Q % growth | 44.719B 5.27% | 43.8B | 919M | 2.10% |
| Q2 2024 Q2Q % growth | 43.223B -0.36% | 43.485B | -262M | -0.60% |
| Q1 2024 Q2Q % growth | 42.273B 0.24% | 43.052B | -779M | -1.81% |
| Q4 2023 Q2Q % growth | 42.454B 6.32% | 42.466B | -12M | -0.03% |
| Q3 2023 Q2Q % growth | 42.48B 6.36% | 43.042B | -562M | -1.31% |
| Q2 2023 Q2Q % growth | 43.377B 12.28% | 41.917B | 1.46B | 3.48% |
| Q1 2023 Q2Q % growth | 42.172B 10.70% | 41.24B | 932M | 2.26% |
| Q4 2022 Q2Q % growth | 39.929B 9.15% | 40.038B | -109M | -0.27% |
| Q3 2022 Q2Q % growth | 39.939B 11.49% | 39.479B | 460M | 1.17% |
| Q2 2022 Q2Q % growth | 38.632B 14.12% | 38.51B | 122M | 0.32% |
| Q1 2022 Q2Q % growth | 38.095B 17.63% | 37.727B | 368M | 0.98% |
| Q4 2021 Q2Q % growth | 36.581B 15.18% | 36.878B | -297M | -0.81% |
| Q3 2021 Q2Q % growth | 35.822B 14.90% | 35.652B | 170M | 0.48% |
| Q2 2021 Q2Q % growth | 33.851B 15.72% | 33.536B | 315M | 0.94% |
| Q1 2021 Q2Q % growth | 32.385B 9.12% | 33.272B | -887M | -2.67% |
| Q4 2020 Q2Q % growth | 31.76B 15.81% | 31.089B | 671M | 2.16% |
| Q3 2020 Q2Q % growth | 31.176B 16.82% | 30.111B | 1.065B | 3.54% |
| Q2 2020 Q2Q % growth | 29.253B 14.84% | 29.542B | -289M | -0.98% |
| Q1 2020 Q2Q % growth | 29.678B 20.27% | 28.885B | 793M | 2.75% |
| Q4 2019 Q2Q % growth | 27.424B | 27.368B | 56M | 0.20% |
| Q3 2019 Q2Q % growth | 26.687B | 26.134B | 553M | 2.12% |
| Q2 2019 Q2Q % growth | 25.473B | 25.12B | 353M | 1.41% |
| Q1 2019 Q2Q % growth | 24.676B | 24.463B | 213M | 0.87% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.07% | -42.6% | -13.1% | -13.15% |
| Revenue | -0.02% | 0.48% | 0.09% | 1.14% |